This inventor holds 1 USPTO granted patent. Top assignees: Helwan University, King Abdulaziz University, University of Jeddah. Active years: 2025.
Company Filing History:
1 out of 1 
1 out of 588 
1 out of 12 Years Active: 2025
Title: Shahenda Mahgoub: Innovator in Pharmaceutical Chemistry
Introduction
Shahenda Mahgoub is a notable inventor based in Cairo, Egypt. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Shahenda Mahgoub holds a patent for "Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer." This patent describes compounds belonging to the group of N-benzyl-2-(4-(4-substituted-1H-1,2,3-triazol-1-yl)phenylacetamides, which exhibit cytotoxic activities against MCF7 breast cancer cells. These compounds are useful in therapeutic regimes for breast cancer and have beneficial effects on BAX, BCL-2, MCL-1, and MAPK pathways within MCF7 breast cancer cells.
Career Highlights
Throughout his career, Shahenda Mahgoub has worked at prestigious institutions such as the University of Jeddah and King Abdulaziz University. His experience in these academic environments has allowed him to advance his research and contribute to the scientific community.
Collaborations
Shahenda has collaborated with notable colleagues, including Roaa M Alreemi and Hind A Alkhatabi. These partnerships have enriched his research and expanded the impact of his work in the field of cancer treatment.
Conclusion
Shahenda Mahgoub is a distinguished inventor whose work in pharmaceutical chemistry has the potential to make a significant impact on breast cancer treatment. His innovative compounds and dedication to research exemplify the importance of scientific advancement in healthcare.